In a report released today, Michael Lavery from Piper Sandler maintained a Buy rating on Post Holdings (POST – Research Report), with a price ...

Piper Sandler named UnitedHealth (NYSE:UNH) and CVS Health (NYSE:CVS) as its top picks in the managed care space, arguing ...

Piper Sandler analyst Michael Lavery maintained a Hold rating on The Hershey Company (HSY – Research Report) today and set a price target of ...

CF Industries Holdings (NYSE:CF) and LSB Industries (LXU) on Monday were upgraded to Overweight from a previous investment ...

Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of John Kerins as a ...

Multiple fertilizer makers are climbing today after investment bank Piper Sandler upgraded several names in the space today.

On Monday, Jan. 7, Michael Lavery at Piper Sandler initiated coverage of the beverage giant, with an overweight rating and a ...

Piper Sandler estimates that AI/HPC data center contracts could potentially triple miner EBITDA at certain sites. The note ...

Piper Sandler Companies is gaining traction with a recovering market. Find out why PIPR stock is becoming an attractive ...

Douglas Emmett Inc (DEI) stock saw a modest uptick, ending the day at $16.69 which represents a slight increase of $0.53 or 3.28% from the prior close of $16.16. The stock opened at $16.17 and touched ...

Biogen (BIIB) stock slipped as Piper Sandler downgraded the company to neutral from overweight, citing challenges in Alzheimer's drug market. Read more here.

Piper Sandler downgraded Poseida Therapeutics (PSTX) to Neutral from Overweight with an unchanged price target of $10 following Roche’s announced acquisition for $9 per share in cash and $4 per ...